FDA approved Adempas for pulmonary hypertension
On Sept. 30, the U.S. Food and Drug Administration (FDA) approved Adempas (riociguat) to treat adults with two forms of pulmonary hypertension. Read more.
News
FDA issues final guidance for mobile medical apps
On Sept. 23, the U.S. Food and Drug Administration (FDA) issued final guidance for developers of mobile medical apps. The agency has cleared about…
FDA approves first generic capecitabine to treat breast and colorectal cancers
On Sept. 16, the U.S. Food and Drug Administration (FDA) approved the first generic version of Xeloda (capecitabine), used to treat metastatic breast and…
Preventing feeding tube misconnections
The U.S. Food and Drug Administration (FDA) has a website dedicated to the issue of tubing and Luer misconnections. The website includes a special…
FDA approves first nonhormonal treatment for hot flashes
On June 28, the U.S. Food and Drug Administration (FDA) approved Brisdelle (paroxetine) to treat moderate to severe hot flashes associated with menopause. Brisdelle,…
FDA recommends healthcare facilities take steps to protect against medical cyberattack
On June 17, the U.S. Food and Drug Administration (FDA) recommended that medical device manufacturers and health care facilities take steps to ensure that…
MedWatch marks 20-year anniversary
One June 3, the U.S. Food and Drug Administration (FDA) posted an article commemorating the 20th anniversary of MedWatch, which collects and reviews reports…
FDA approves Simponi for ulcerative colitis
May 15, the U.S. Food and Drug Administration (FDA) approved a new use for Simponi (golimumab) injection: to treat adults with moderate to severe…
FDA announces import of injectable drugs used in TPN to ease shortage
On May 29, the U.S. Food and Drug Administration (FDA) announces that injectable drugs used in total parenteral nutrition (TPN) will be imported into…
Stay informed of recalls through MedWatch
To keep current on recalls announced by the U.S. Food and Drug Administration, sign up for one of several options through the agency’s MedWatch…
FDA recommends manufacturers stop using ‘latex-free’ labeling
On March 29, the U.S. Food and Drug Administration (FDA) recommended that manufacturers stop using labels such as “latex-free” or “does not contain latex”…
FDA approves Diclegis for pregnant women who have nausea and vomiting
On April 8, the U.S. Food and Drug Administration (FDA) approved Diclegis (doxylamine succinate and pyridoxine hydrochloride) to treat pregnant women experiencing nausea and…
FDA approved Adempas for pulmonary hypertension
On Sept. 30, the U.S. Food and Drug Administration (FDA) approved Adempas (riociguat) to treat adults with two forms of pulmonary hypertension.…
FDA issues final guidance for mobile medical apps
On Sept. 23, the U.S. Food and Drug Administration (FDA) issued final guidance for developers of mobile medical apps. The agency has…
FDA approves first generic capecitabine to treat breast and colorectal cancers
On Sept. 16, the U.S. Food and Drug Administration (FDA) approved the first generic version of Xeloda (capecitabine), used to treat metastatic…
Preventing feeding tube misconnections
The U.S. Food and Drug Administration (FDA) has a website dedicated to the issue of tubing and Luer misconnections. The website includes…
FDA approves first nonhormonal treatment for hot flashes
On June 28, the U.S. Food and Drug Administration (FDA) approved Brisdelle (paroxetine) to treat moderate to severe hot flashes associated with…
FDA recommends healthcare facilities take steps to protect against medical cyberattack
On June 17, the U.S. Food and Drug Administration (FDA) recommended that medical device manufacturers and health care facilities take steps to…
MedWatch marks 20-year anniversary
One June 3, the U.S. Food and Drug Administration (FDA) posted an article commemorating the 20th anniversary of MedWatch, which collects and…
FDA approves Simponi for ulcerative colitis
May 15, the U.S. Food and Drug Administration (FDA) approved a new use for Simponi (golimumab) injection: to treat adults with moderate…
FDA announces import of injectable drugs used in TPN to ease shortage
On May 29, the U.S. Food and Drug Administration (FDA) announces that injectable drugs used in total parenteral nutrition (TPN) will be…
Stay informed of recalls through MedWatch
To keep current on recalls announced by the U.S. Food and Drug Administration, sign up for one of several options through the…
FDA recommends manufacturers stop using ‘latex-free’ labeling
On March 29, the U.S. Food and Drug Administration (FDA) recommended that manufacturers stop using labels such as “latex-free” or “does not…
FDA approves Diclegis for pregnant women who have nausea and vomiting
On April 8, the U.S. Food and Drug Administration (FDA) approved Diclegis (doxylamine succinate and pyridoxine hydrochloride) to treat pregnant women experiencing…
Test Your Knowledge
skin cancer tyk
Get your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.NurseLine Newsletter
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.